(19)
(11) EP 2 831 229 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.10.2018 Bulletin 2018/42

(45) Mention of the grant of the patent:
18.10.2017 Bulletin 2017/42

(21) Application number: 13716577.5

(22) Date of filing: 25.03.2013
(51) International Patent Classification (IPC): 
C12N 9/88(2006.01)
(86) International application number:
PCT/US2013/033716
(87) International publication number:
WO 2013/148580 (03.10.2013 Gazette 2013/40)

(54)

PURIFICATION OF CYSTATHIONINE BETA-SYNTHASE

REINIGUNG VON CYSTATHIONIN-BETA-SYNTHASE

PURIFICATION DE LA CYSTATHIONINE BETA SYNTHASE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 26.03.2012 US 201261615629 P
14.03.2013 US 201313830494

(43) Date of publication of application:
04.02.2015 Bulletin 2015/06

(60) Divisional application:
17165825.5 / 3263701

(73) Proprietor: The Regents of the University of Colorado, a body corporate
Denver, CO 80203 (US)

(72) Inventors:
  • CARRILLO, Richard, G.
    Oakland, CA 94609 (US)
  • KRAUS, Jan, P.
    Littleton, CO 80123 (US)
  • MAJTAN, Tomas
    Aurora, CO 80011 (US)
  • NAVEH, David
    Piedmont, CA 94611 (US)

(74) Representative: Rees, Kerry et al
WP Thompson 138 Fetter Lane
London EC4A 1BT
London EC4A 1BT (GB)


(56) References cited: : 
EP-A1- 1 396 537
WO-A1-95/07714
WO-A2-2011/097381
EP-A1- 1 878 739
WO-A2-03/106971
   
  • BELEW M S ET AL: "Kinetic characterization of recombinant human cystathionine beta-synthase purified from E. coli", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, vol. 64, no. 2, 1 April 2009 (2009-04-01), pages 139-145, XP025924316, ISSN: 1046-5928, DOI: 10.1016/J.PEP.2008.10.012 [retrieved on 2008-10-30]
  • FRANK ET AL: "Purification and characterization of the wild type and truncated human cystathionine beta-synthase enzymes expressed in E. coli", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, ACADEMIC PRESS, US, vol. 470, no. 1, 17 November 2007 (2007-11-17), pages 64-72, XP022424131, ISSN: 0003-9861, DOI: 10.1016/J.ABB.2007.11.006
  • ROMAN VOZDEK ET AL: "Novel structural arrangement of nematode cystathionine [beta]-synthases: characterization of Caenorhabditis elegans CBS-1", BIOCHEMICAL JOURNAL, vol. 16, no. 2, 15 April 2012 (2012-04-15) , pages 1066-547, XP055066236, ISSN: 0264-6021, DOI: 10.1534/genetics.111.129841
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).